glutathione is included in a tbi patient's treatment New insights into metabolism dysregulation after | Journal of Neuroinflammation Antioxidant Therapies in Traumatic Brain
Description
A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism
B12 injections are most appropriate for people with confirmed or suspected B12 deficiency
Hypothyroidism is the most common in clinical practice
His parents had already moved to Israel
